Home » Topics » BioWorld Science

BioWorld Science
RSS

Therapeutics Solutions reports preclinical data on CampbellCell stem cell therapy for schizophrenia

Feb. 15, 2022

Adcentrx and AvantGen partner to discover antibodies for ADC candidates

Feb. 15, 2022

Studies at CROI show interferons' complex effects, therapeutic potential

Feb. 15, 2022

SETD2 loss promotes tumor metastasis in ccRCC

Feb. 15, 2022

PSD3 downregulation as new therapeutic strategy against FLD

Feb. 15, 2022

Cofilin siRNA, a promising therapy for treatment of hemorrhagic stroke

Feb. 15, 2022

Mutant SLC6A8 correctors patented by Jnana Therapeutics

Feb. 15, 2022

New complement C1s subcomponent inhibitors discovered at Annexon

Feb. 15, 2022

Dual PI3K-delta/PI3K-gamma inhibitors identified at National Institute of Pharmaceutical R&D Co.

Feb. 15, 2022

Ubix Therapeutics presents PROTAC androgen receptor degraders

Feb. 15, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...